ATE550326T1 - Als modulatoren von hdl einsetzbare verbindungen - Google Patents

Als modulatoren von hdl einsetzbare verbindungen

Info

Publication number
ATE550326T1
ATE550326T1 AT07866668T AT07866668T ATE550326T1 AT E550326 T1 ATE550326 T1 AT E550326T1 AT 07866668 T AT07866668 T AT 07866668T AT 07866668 T AT07866668 T AT 07866668T AT E550326 T1 ATE550326 T1 AT E550326T1
Authority
AT
Austria
Prior art keywords
hdl
modulators
compounds
synthesis
pharmaceutically acceptable
Prior art date
Application number
AT07866668T
Other languages
English (en)
Inventor
Pravin S Thombare
Braj Bhushan Lohray
Vidya Bhushan Lohray
Pankaj Ramanbhai Patel
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Application granted granted Critical
Publication of ATE550326T1 publication Critical patent/ATE550326T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07866668T 2006-07-31 2007-07-27 Als modulatoren von hdl einsetzbare verbindungen ATE550326T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1213MU2006 2006-07-31
PCT/IN2007/000321 WO2008059513A2 (en) 2006-07-31 2007-07-27 Compounds suitable as modulators of hdl

Publications (1)

Publication Number Publication Date
ATE550326T1 true ATE550326T1 (de) 2012-04-15

Family

ID=39402095

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07866668T ATE550326T1 (de) 2006-07-31 2007-07-27 Als modulatoren von hdl einsetzbare verbindungen

Country Status (4)

Country Link
US (1) US8022217B2 (de)
EP (1) EP2049493B1 (de)
AT (1) ATE550326T1 (de)
WO (1) WO2008059513A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2352398B1 (es) * 2009-06-25 2011-09-29 Institut Univ. De Ciencia I Tecnologia S.A. N-fenetilsulfonamidas-n-sustituidas para la identificacion de actividad biologica y farmacologica.
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
JP6744218B2 (ja) * 2013-11-15 2020-08-19 ザ ウィスター インスティテュート オブ アナトミー アンド バイオロジー Ebna1阻害剤およびそれらの使用方法
BR112017024481B1 (pt) 2015-05-14 2020-11-17 The Wistar Institute Of Anatomy And Biology composto inibidor de ebna1, composição farmacêutica compreendendo dito composto e usos terapêuticos do mesmo
CN112543634A (zh) 2018-05-17 2021-03-23 威斯达研究所 Ebna1抑制剂晶体形式及其制备和使用方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12617A (en) * 1973-04-13 1979-07-05 Thomae Gmbh Dr K Aminobenzyl-amides and salts thereof
US5728835A (en) * 1993-12-27 1998-03-17 Toa Eiyo, Ltd. Substituted cyclic amine compound, production process thereof and pharmaceutical composition for circulatory organ use containing the same
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
CZ289721B6 (cs) * 1995-05-19 2002-03-13 Syngenta Participations Ag Způsob katalytické hydrogenace aromatických nitrosloučenin
EP0881220A4 (de) * 1996-02-15 1999-04-21 Mitsubishi Chem Corp Diarylsultam-derivate
GB9824579D0 (en) * 1998-11-10 1999-01-06 Novartis Ag Organic compounds
IL149462A0 (en) * 2001-05-09 2002-11-10 Warner Lambert Co Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
ES2277142T3 (es) 2002-08-30 2007-07-01 Japan Tobacco Inc. Compuesto de dibencilamina y su uso medicinal.
AR042067A1 (es) * 2002-11-27 2005-06-08 Bayer Pharmaceuticals Corp Derivados de anilinopirazol utiles en el tratamiento de la diabetes
FR2850654A1 (fr) * 2003-02-03 2004-08-06 Servier Lab Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6987174B2 (en) * 2003-04-01 2006-01-17 Fuji Photo Film Co., Ltd. Azo compound, colorant-containing curable composition, color filter and color filter production method
WO2005033082A2 (en) * 2003-09-30 2005-04-14 Pfizer Products Inc. Cetp inhibitors and metabolites thereof
CN1993323B (zh) 2004-08-05 2011-04-20 霍夫曼-拉罗奇有限公司 吲哚,吲唑或二氢吲哚衍生物
US7572823B2 (en) * 2006-02-07 2009-08-11 Hoffmann-La Roche Inc. Heteroaryl carboxamide compounds
US7678818B2 (en) * 2006-02-07 2010-03-16 Hoffmann-La Roche Inc. Anthranilamide and 2-amino-heteroarene-carboxamide compounds
ES2359744T3 (es) 2006-02-07 2011-05-26 F. Hoffmann-La Roche Ag Derivados de la benzamida y del heteroareno como inhibidores de la cetp.

Also Published As

Publication number Publication date
US20090171091A1 (en) 2009-07-02
WO2008059513A3 (en) 2008-08-28
WO2008059513A2 (en) 2008-05-22
EP2049493B1 (de) 2012-03-21
US8022217B2 (en) 2011-09-20
EP2049493A2 (de) 2009-04-22

Similar Documents

Publication Publication Date Title
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
HRP20070076A2 (en) Pyrimidine derivatives
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
TW200716121A (en) Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
TW200732323A (en) Organic compounds
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
CY1108880T1 (el) Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα
TW200612936A (en) Indole derivatives
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
TNSN07006A1 (en) Novel heterocyclic compounds
JO2749B1 (en) Indole-2-Wen derivatives bilaterally substituted at position 3, their preparation and therapeutic application
TW200716568A (en) 1H-quinazoline-2,4-diones
BRPI0519292A2 (pt) compostos orgÂnicos
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
TW200745122A (en) New compounds I
TW200702330A (en) 3,4,5-Substituted piperidines
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
MX2009010225A (es) Nuevos compuestos 707 y sus usos.